Treatment regimen

Effective

(%)

ATRIPLA (TDF + FTC + EFV)

29

58.9%

TLD (TDF + 3TC + DTG)

16

32.9%

TDF + 3TC + EFV

2

4.1%

AZT + 3TC + Lopinavire/Ritonavir (Lpv/r)

2

4.1%

Total

49

100%